High Tide Inc.

NASDAQ:HITI

Medical - Pharmaceuticals

Healthcare
$2.37 -2.11%

-$0.05 today

Market cap
$211.27M
Beta
0.57
P/E (TTM)
-6.6
EPS (TTM)
-$0.50
52W Low $2.12High $4.06

Volume 0.32M

Average 0.61M

HITI EPS (Diluted)

Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.

High Tide Inc.NASDAQ: HITI

EPS (Diluted) · Q2 FY2026 · quarter ended Apr 2026

EPS (Diluted) remains negative

Q2 FY2026 EPS (Diluted) was -CA$0, compared with -CA$0.04 a year earlier. Trailing-twelve-month EPS (Diluted) was -CA$0.5.

Context

  • EPS (Diluted) grew in size in 1 of the last 3 fiscal years.

What to watch

Whether EPS (Diluted) reaches the consensus estimate from 4 analysts of CA$0.16 (+125.6%) for the fiscal year ending Oct 2026, a step up from the -1037.6% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterApr 2026
-CA$0-115.9% QoQ
Last fiscal yearOct 2025
-CA$0.62-1037.6% YoY
LTMApr 2026
-CA$0.5-607.5% YoY
EPS (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+94.5%+139.8%+45.3 pp
1 year-1037.6%+125.6%+1163.2 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EPS (Diluted) history

CAD · from the income statement

Latest · FY2025
(0.62) CAD
Year-over-year change
-1037.6%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EPS (Diluted) vs competitors

How HITI compares with its peers on the latest reported figures

  • Peers report in different currencies, so EPS (Diluted) is compared through growth and rates rather than absolute size.
  • Its year-over-year change of -607.5% is the lowest of 6, against a peer median of -2.6%.
HITI Competitors
EPS (Diluted) for HITI and competitors
Company Period LTM YoY 3-year CAGR
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$0.02 CAD+32.5%—
CRON.TOCronos Group Inc.LTM Mar 2026-$0 USD-101.9%—
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026-CA$0.18 CAD-291.9%—
TSND.TOTerrAscend Corp.LTM Mar 2026-$0.27 USD-2.6%—
HITIHigh Tide Inc.LTM Apr 2026-CA$0.5 CAD-607.5%—
WEED.TOCanopy Growth CorporationLTM Mar 2026-CA$0.86 CAD+84.7%—
Peer median (excluding HITI) —-2.6%—

Competitors are the stored peer set for HITI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Oct 2021
FY2022
Oct 2022
FY2023
Oct 2023
FY2024
Oct 2024
FY2025
Oct 2025
Revenue181.12M356.85M487.67M522.31M593.99M
Cost of Revenue117.14M255.9M356.36M379.8M440.46M
Gross Profit63.98M100.95M131.31M142.5M153.53M
Gross Margin35.3%28.3%26.9%27.3%25.8%
Research & Development00000
Selling, General & Admin54.27M90.9M101.21M101.79M113.78M
Operating Expenses82.66M173.26M172.74M137.5M167.98M
Depreciation & Amortization23.57M30.17M32.76M25.39M24.31M
EBITDA(1.96M)(33.65M)(4.2M)33.78M(13.74M)
EBITDA Margin-1.1%-9.4%-0.9%6.5%-2.3%
Operating Income(18.67M)(72.31M)(41.43M)5M(14.45M)
Operating Margin-10.3%-20.3%-8.5%1.0%-2.4%
Interest Income00000
Interest Expense10.24M9.95M11.64M12.79M13.38M
Other Income / Expenses(17.09M)(1.45M)(7.17M)(9.41M)(36.98M)
Income Before Tax(35.77M)(73.76M)(48.6M)(4.4M)(51.43M)
Pre-Tax Margin-19.7%-20.7%-10.0%-0.8%-8.7%
Income Tax Expense(730K)(2.92M)(7.64M)(593K)(25K)
Net Income(34.36M)(71.76M)(39.31M)(4.34M)(50.75M)
Net Margin-19.0%-20.1%-8.1%-0.8%-8.5%
EPS (Basic)(0.83)(1.13)(0.53)(0.05)(0.62)
EPS (Diluted)(0.83)(1.13)(0.53)(0.05)(0.62)
Weighted Avg Shares42.43M62.78M74.33M79.56M82.18M
Weighted Avg Shares (Diluted)42.43M62.78M74.33M79.56M82.18M

High Tide Inc.

NASDAQ:HITI

Intrinsic Alpha fair value

Locked

Current Price

$2.37

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.